ALPPS technique for two-stage liver resections: immediate and long-term results
Authors:
- D. V. PodluzhnyiDPD. V. Podluzhnyi
- Yu. I. PatyutkoYPYu. I. Patyutko
- А. Г. КотельниковАКА. Г. Котельников
- I. V. SagaydakISI. V. Sagaydak
- N. E. KudashkinNKN. E. Kudashkin
- A. N. PolyakovAPA. N. Polyakov
- B. I. SakibovBSB. I. Sakibov
- N. A. PeregudovNPN. A. Peregudov
- K. A. RomanovaKRK. A. Romanova
- O. A. EgenovOEO. A. Egenov
Open Access
- 21 September 2023
- journal article
- research article
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 28 (3) , 39-47
Abstract
Aim. To evaluate the immediate and long-term results of two-stage liver resection performed by means of ALPPS technique.Materials and methods. The retrospective analysis involved 7 patients (mean age 62 years) with intact liver parenchyma volume (Future Liver Remnant, FLR) Results. The median duration of ALPPS stage I was 250 min, median blood loss was 600 ml, and stage II – 210 min and 300 ml, correspondingly. The median FLR before and after ALPPS stage I was 15.3% and 31.6%. The median FLR hypertrophy after ALPPS stage I accounted for 123%. The median interval between stage I and II of ALPPS was 10 days. All patients underwent R0 resection. The incidence of postoperative complications after ALPPS stage I was 14.3% (Clavien–Dindo I), after stage II – 57.1% (Clavien–Dindo III–V). The mortality rate within 90 days after ALPPS stage II accounted for 14.3%. Median follow-up was 25 months. The median time without progression in 6 patients operated for colorectal cancer metastases was 6 months, the median life expectancy was 31 months. The patient who underwent ALPPS for hepatocellular carcinoma is alive, no signs of disease progression have been detected.Conclusion. ALPPS provides a rapid and more than two-fold growth in FLR and increases the likelihood of R0 resection in patients with initially unresectable primary and secondary liver tumors. However, the immediate results of ALPPS are unsatisfactory. The indications for surgery are extremely controversial due to the development of drug therapies, ablation techniques and radiotherapy.Keywords
This publication has 21 references indexed in Scilit:
- Analysis of the Efficacy of Portal Vein Embolization for Patients with Extensive Liver Malignancy and Very Low Future Liver Remnant Volume, Including a Comparison with the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy ApproachJournal of the American College of Surgeons, 2013
- ALPPS in Right Trisectionectomy: a Safe Procedure to Avoid Postoperative Liver Failure?Journal of Gastrointestinal Surgery, 2013
- Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases and Small Future Liver RemnantJournal of the American College of Surgeons, 2013
- Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size SettingsAnnals of Surgery, 2012
- Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)Surgery, 2011
- Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver SurgerySurgery, 2011
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Right Portal Vein Ligation is as Efficient as Portal Vein Embolization to Induce Hypertrophy of the Left Liver RemnantJournal of Gastrointestinal Surgery, 2007
- Portal Vein Embolization vs. Portal Vein Ligation for Induction of Hypertrophy of the Future Liver RemnantJournal of Gastrointestinal Surgery, 2002